Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) compounds represent a major shift in how healthcare providers address obesity and metabolic health. These medications work by signaling your brain's appetite centers and slowing stomach emptying, creating sustained feelings of fullness. PlexusDx specializes in compounded GLP-1 therapies tailored to individual genetic profiles and treatment goals.

What Exactly Is a GLP-1 Compound?

A GLP-1 compound is a prescription medication that replicates the function of glucagon-like peptide-1, a hormone your intestines naturally produce when you eat. Instead of using pre-filled pens from major pharmaceutical manufacturers, compounded versions are created by licensed 503A compounding pharmacies specifically for individual patients. This allows for flexible dosing schedules, alternative delivery methods (injection or oral), and cost-effective access without insurance requirements.

The active medications in PlexusDx compounds—semaglutide and tirzepatide—are the same molecules studied in major clinical trials showing weight reductions of 15–22% over 68 weeks. The difference lies in customization: your dose can be adjusted based on your response and tolerance, and your price remains flat regardless of dose level. This personalized approach means you pay one monthly fee while your healthcare provider optimizes your therapy over time.

How GLP-1 Compounds Work in Your Body

GLP-1 compounds activate specific receptors in your brain, pancreas, and gastrointestinal tract. In the hypothalamus (your appetite control center), they increase satiety signals and decrease hunger drive. Simultaneously, they slow gastric emptying—the rate at which food leaves your stomach—extending feelings of fullness after meals. This dual mechanism reduces overall calorie intake without requiring willpower-based food restriction.

Tirzepatide, available through PlexusDx as an injection or oral formulation, works on two receptor pathways: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual action may explain why some patients experience greater weight loss with tirzepatide compared to semaglutide alone. Your genetic profile—measured through PlexusDx's Precision Peptide Genetic Test—can reveal whether you're more likely to respond to single or dual-receptor therapies.

Key Differences Between Compounded and Brand-Name GLP-1s

Brand-name GLP-1 medications (like Ozempic or Mounjaro) are manufactured by large pharmaceutical companies and typically cost $900–$1,500 monthly without insurance. Compounded versions from licensed 503A pharmacies contain the same active pharmaceutical ingredients but are prepared individually and cost significantly less. PlexusDx compounded semaglutide injections start at $149 per month, and tirzepatide begins at $249 monthly—making personalized GLP-1 therapy accessible regardless of insurance status.

Both compounded and brand-name formulations are prescription medications that must be obtained through a licensed healthcare provider. Neither is FDA-approved in the traditional sense; compounded medications operate under FDA regulations for 503A pharmacies. The clinical outcomes—weight loss, appetite reduction, improved metabolic markers—are equivalent when doses are appropriately managed. PlexusDx patients receive ongoing monitoring and dose adjustments at no additional cost.

Benefits of Choosing a Compounded GLP-1 Program

Affordability stands as the primary advantage: PlexusDx eliminates insurance requirements, membership fees, and flat per-compound pricing. Your monthly cost remains flat whether you're at a 0.5 mg or 2.4 mg weekly semaglutide dose. This pricing model removes barriers for uninsured patients and those with high deductible plans, while HSA and FSA accounts can be applied to reduce out-of-pocket expenses even further.

Personalization through genetic testing offers another distinct benefit. PlexusDx's Precision Peptide Genetic Test ($99 after your first treatment month) analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 additional peptide pathways across 49 total markers. Understanding your genetic predispositions helps your provider select whether semaglutide, tirzepatide, or a combination therapy (GLP-Squared) aligns best with your biological response patterns. Flexibility in delivery—choosing between weekly injections or daily oral tablets—accommodates individual preferences and lifestyles.

Are GLP-1 Compounds Safe and Effective?

GLP-1 compounds have been prescribed for diabetes management since 2005 and have accumulated over 15 years of safety data in clinical use. Large randomized controlled trials in 2021–2023 demonstrated sustained weight loss, improved cardiovascular outcomes, and metabolic improvements in people with obesity. The most common side effects—nausea, constipation, and decreased appetite—typically mild to moderate and often resolve within 4–8 weeks as your body adjusts.

Effectiveness depends on consistent use, appropriate dose escalation, and lifestyle integration. Clinical trials show weight reductions of 15–22% with semaglutide and 20–22% with tirzepatide when combined with modest dietary changes and physical activity. PlexusDx provides ongoing clinical oversight: your healthcare provider monitors your progress, adjusts dosing as needed, and addresses any concerns. Genetic testing through PlexusDx can further optimize your response by identifying whether you're a strong responder to GLP-1 or may benefit from tirzepatide's dual-pathway action.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is a compounded GLP-1 from PlexusDx the same medicine as brand-name Ozempic or Mounjaro?

Yes, compounded semaglutide and tirzepatide contain identical active pharmaceutical ingredients to their brand-name equivalents. The difference is preparation method and cost: PlexusDx uses licensed 503A compounding pharmacies, which customize doses for individual patients, while brand-name versions are mass-manufactured. Clinical outcomes are equivalent when doses are properly managed and monitored.

What clinical evidence supports GLP-1 compounds for weight loss?

The STEP trials (2021) demonstrated that semaglutide produced 15% average weight loss over 68 weeks in people with obesity. Tirzepatide trials showed 20–22% weight reductions due to its dual GLP-1/GIP mechanism. Both medications also improved cardiovascular risk factors, including blood pressure and cholesterol, in published research.

How much does PlexusDx compounded semaglutide cost, and does it work without insurance?

PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, no membership fees, and no flat per-compound pricing increases. HSA and FSA accounts are eligible. All 50 states are served, making this option accessible to uninsured patients and those seeking alternatives to high-deductible insurance plans.

What side effects should I expect when starting a GLP-1 compound?

Common early side effects include mild nausea, constipation, and reduced appetite—the mechanism you want therapeutically. These typically resolve within 4–8 weeks. More serious but rare complications include pancreatitis or gallbladder issues. PlexusDx healthcare providers screen for contraindications at baseline and monitor for adverse events throughout treatment.

How does the Precision Peptide Genetic Test help personalize my GLP-1 therapy?

PlexusDx's Precision Peptide Genetic Test ($99 after first month) analyzes 150+ genetic insights across 49 peptide markers in 14 pathways, including GLP1R and GIPR variants. Results reveal whether you're genetically predisposed to strong GLP-1 response, and may help your provider recommend tirzepatide or dual-compound therapy (GLP-Squared) if single-agent semaglutide may be suboptimal for your biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves